Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a daily supplement ease Kids' constipation?

NCT ID NCT07580729

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a daily mix of a special fiber (guar gum) and a probiotic (Lacticaseibacillus rhamnosus GG) could help children with long-term constipation. Fifty-two children aged 4 to 16 took either the supplement plus diet advice or just diet advice for 12 weeks. Researchers checked if bowel movements improved and if gut bacteria changed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
partially hydrolyzed guar gum and Lacticaseibacillus rhamnosus GG (a dietary supplement combining a fiber and a probiotic)
What this could lead to
If it works, this could offer a simple, natural option to help children with constipation have more regular and comfortable bowel movements.
What could go wrong
This is a small, completed trial with only 52 children, so results may not apply to everyone. The supplement might not work better than standard dietary advice alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

52 people

The number who actually took part.

Started

Aug 2024

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥4 years * Diagnosis of functional constipation per Rome IV * Parental informed consent Exclusion Criteria: * Organic causes of constipation * Chronic medication use * Antibiotics or biotics within 8 weeks * Age \<4 years

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Constipation - functional are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Health Sciences, Sancaktepe Training and Research Hospital

    Istanbul, 34000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.